Heron Therapeutics, Inc. /De/
HRTX· Manufacturing· Fiscal year ends in December
Craig Collard is the CEO of Heron Therapeutics, Inc. /De/ and was paid $3.5M in FY2025 (Dec), up 147%.
Executives4
See all- 1Mark HensleyEVP, Chief Operating OfficerFY2025
- 2Craig CollardChief Executive OfficerFY2025
- 3William ForbesEVP, Chief Development OfficerFY2025
- 4Ira DuarteEVP, Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allHeron Therapeutics, Inc. /De/ paid its 4 named executives $11.1M in total in FY2025 (Dec). CEO Craig Collard was paid $3.5M of that.
| Name | |||
|---|---|---|---|
| Mark HensleyEVP, Chief Operating Officer | |||
| Craig CollardChief Executive Officer | |||
| William ForbesEVP, Chief Development Officer | |||
| Ira DuarteEVP, Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2025 (Dec) proxy of Heron Therapeutics, Inc. /De/ names 19 peer companies for pay. Among Heron Therapeutics, Inc. /De/ and these peers, CEO pay was the lowest of 7 and total shareholder return was the lowest of 7.
7th highest of 7in Heron Therapeutics, Inc. /De/ and its pay peers, FY2025 (Dec) by CEO pay:
7th highest of 7in Heron Therapeutics, Inc. /De/ and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Adam MorganChair · 2 yr on the boardIndependent—Paid as an executive
- Christian WaageDirector · 9 yr on the boardIndependentAudit, Governance (Chair)—Paid as an executive
- Michael KasetaDirector · 1 yr on the boardIndependentAudit, Compensation—Paid as an executive
- Tom CusackDirector · 0 yr on the boardIndependentGovernance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 30, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 30, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Mar 12, 2024 | FY2023 |
